(Q34663159)

3 August 2017

1 reference

title

Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability (English)

1 reference

3 August 2017

1 reference

Curzon G

1 reference

3 August 2017

Gibson EL

series ordinal

1 reference

3 August 2017

Oluyomi AO

series ordinal

1 reference

3 August 2017

publication date

1 January 1997

1 reference

Trends in Pharmacological Sciences

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

21-25

1 reference

3 August 2017

cites work

Importance of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Clinical studies with dexfenfluramine: from past to future

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Psychological and metabolic effects of dietary carbohydrates and dexfenfluramine during a low-energy diet in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Radiofrequency lesions of the PVN fail to modify the effects of serotonergic drugs on food intake

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

d-Fenfluramine- and d-norfenfluramine-induced hypophagia: differential mechanisms and involvement of postsynaptic 5-HT receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

D-Fenfluramine and D-norfenfluramine reduce food intake by acting on different serotonin mechanisms in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Fenfluramine's appetite suppression and serotonin neurotoxicity are separable.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Appetite suppressants. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Role of serotonin and catecholamines in brain in the feeding suppressant effect of fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

An investigation of the mechanism responsible for fluoxetine-induced hypophagia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Reduction of feeding behavior by the serotonin uptake inhibitor sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Role of serotonin receptors in the effect of sertraline on feeding behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Quantitative morphometric analysis of two types of serotonin-immunoreactive nerve fibres differentially responding to p-chlorophenylalanine treatment in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Effects of dl-fenfluramine and xylamidine on gastric emptying of maintenance diet in freely feeding rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Role of 5-HT receptors in the effect of d-fenfluramine on gastric emptying and feeding behaviour as examined in the runway test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Single- and multiple-dose kinetics of d-fenfluramine in rats given anorectic and toxic doses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Diminished amphetamine anorexia and enhanced fenfluramine anorexia after midbrain 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Ineffectiveness of hypothalamic serotonin to block neuropeptide Y-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Cotransport of sodium and chloride by the adult mammalian choroid plexus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Effects of d-fenfluramine on feeding and hypothalamic 5-hydroxytryptamine and dopamine in male and female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

Gender bias in the preclinical psychopharmacology of anxiety: male models for (predominantly) female disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2896%2901003-6

7 January 2021

10.1016/S0165-6147(96)01003-6

Identifiers

DOI

1 reference

3 August 2017

1 reference